- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04170868
Psychoeducational Video Series - Proof of Concept
Study Overview
Detailed Description
The study will consist of four phases, each involving the completion of several self-report metrics following video exposure or the lack thereof. The investigators expect 30-40 patients to progress through a quadriphasic design.
Phase 1:
Upon understanding and signing an informed consent form, participants will complete a short demographics questionnaire that will enquire into their age, education level, and gender, but will not include specific identifying information such as name, initials, email, or home address.
Next, participants will be asked to complete a survey containing both the Tuckman Condensed Procrastination Scale (TCPS) and the Adult ADHD Self-Report Scale (ASRS). The data that are gathered from the ASRS will be used as a core inclusion-exclusion metric.
Finally, participants will be briefed on the video access system and then given their unique login credentials, which allow the investigators to track individual usage metrics. The investigators will then explain that for the next ten days the participant will have unlimited access to a single, randomly assigned experimental video (with participants split between one of two videos) adding that at the third and seventh days the participant will receive-pending consent-a friendly email reminder of their ability to access the video. Any questions will be addressed at this point.
All in, the time required to complete Phase 1 for a single participant will be 30-45 minutes.
Phase 2:
After ten days have elapsed, the participant will be sent an online survey link containing the TCPS, ASRS, and a Video Review Survey. The email will also explain how video access over the upcoming ten days will be restricted-as Phase 3 of the study commences-but that they need not worry as full-access will be reinstated following completion of the study. With that, participants will be reminded of the investigator's contact information and left to continue using the learned strategies for the upcoming ten days.
Phase 3:
Following the ten day washout period, participants will be sent another online survey link containing the TCPS and ASRS. The email will also contain access to the second of the two videos, along with a re-explanation of how the investigators hope they use it. From here, another ten-day exposure period will begin.
Phase 4:
After completing the second ten-day exposure period (totalling one month's time), the participant will be asked to answer a final Future Video Survey. Once the survey has been answered, the participant will have finished the study and will be thanked for their time. A contact address and number will be included in the email in the case of any unresolved question, and a link will be provided to reinstate participant video access.
Study Type
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 and up
- Ability to fill out a computerized form
- Ability to access the Internet
- Ability/Willingness to watch several psychoeducational videos
- Ability/Willingness to understand and abide by the procedures and the acknowledge disclosure statement
- The participants in the ADHD group must be diagnosed by a psychiatrist. Diagnosis will be confirmed by re-evaluation using the Adult ADHD Self-Report Scale (ASRS)
Exclusion Criteria:
- Under 18 years of age
- Inability to fill out a computerized form
- Does not currently have Internet access
- Inability/Unwillingness to watch several psychoeducational videos
- Inability/Unwillingness to understand and abide by the procedures and acknowledge disclosure statement
- The participant has not been diagnosed with ADHD by a psychiatrist. Or, the diagnosis does not meet confirmation following re-evaluation using the Adult ADHD Self-Report Scale (ASRS)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Video 1
Ten-day exposure to one of two randomly assigned psychoeducational videos.
Administration of outcome measures pre and post.
|
The videos will disseminate evidence-based strategies for the management of Attention Deficit Hyperactivity Disorder (ADHD).
Each video, roughly two minutes, will both introduce the viewer to a single ADHD management strategy and explain how said strategy can effectively be integrated into their life.
|
NO_INTERVENTION: Video 1 Washout
Ten-day washout period between access to the first and second videos.
|
|
OTHER: Video 2
Ten-day exposure to the second of the two randomly assigned psychoeducational videos.
Administration of outcome measures pre and post.
|
The videos will disseminate evidence-based strategies for the management of Attention Deficit Hyperactivity Disorder (ADHD).
Each video, roughly two minutes, will both introduce the viewer to a single ADHD management strategy and explain how said strategy can effectively be integrated into their life.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Tuckman Condensed Procrastination Scale (TCPS) Change (Video One)
Time Frame: Measured at days 0 and 10. Day 0 serves as a baseline for changes at Day 10 following exposure to video one.
|
The TCPS is a 16-question condensed version of the original Tuckman Procrastination Scale and has been validated as the gold standard for the evaluation of procrastination proclivity.
The TCPS assesses respondent behaviour by posing self-statements that can either be agreed or disagreed with on a four-point Likert-type scale.
Out of the sixteen questions, five are reversed coded to promote accurate responding.
|
Measured at days 0 and 10. Day 0 serves as a baseline for changes at Day 10 following exposure to video one.
|
Tuckman Condensed Procrastination Scale (TCPS) Change (Video Two)
Time Frame: Measured at days 20 and 30. Day 20 serves as a quasi-baseline--following washout--for changes at Day 30 following exposure to video two.
|
The TCPS is a 16-question condensed version of the original Tuckman Procrastination Scale and has been validated as the gold standard for the evaluation of procrastination proclivity.
The TCPS assesses respondent behaviour by posing self-statements that can either be agreed or disagreed with on a four-point Likert-type scale.
Out of the sixteen questions, five are reversed coded to promote accurate responding.
|
Measured at days 20 and 30. Day 20 serves as a quasi-baseline--following washout--for changes at Day 30 following exposure to video two.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adult ADHD Self-Report Scale (ASRS) Change (Video One)
Time Frame: Measured at days 0 and 10. Day 0 serves as a baseline for changes at Day 10 following exposure to video one.
|
The ASRS is an 18-item self-report screening scale used to assess adult ADHD.
Each ASRS item contains a five-point scale where participants indicate how frequently they conduct themselves in the described manner; item responses can range from 'Never' to 'Very Often', where responses of 'Often' or 'Very Often' are consistent with ADHD typical dysfunction.
When participant responses meet the criterion for ADHD typical dysfunction on at least 4 out of 6 screener items (denoted as 'Part A'), said participant will meet inclusion for the study.
The remaining 12 ASRS items ('Part B') will be administered for use in the event that the screener criteria are met, and thus a need for further psychometric gradation arises.
|
Measured at days 0 and 10. Day 0 serves as a baseline for changes at Day 10 following exposure to video one.
|
Adult ADHD Self-Report Scale (ASRS) Change (Video Two)
Time Frame: Measured at days 20 and 30. Day 20 serves as a quasi-baseline--following washout--for changes at Day 30 following exposure to video two.
|
The ASRS is an 18-item self-report screening scale used to assess adult ADHD.
Each ASRS item contains a five-point scale where participants indicate how frequently they conduct themselves in the described manner; item responses can range from 'Never' to 'Very Often', where responses of 'Often' or 'Very Often' are consistent with ADHD typical dysfunction.
When participant responses meet the criterion for ADHD typical dysfunction on at least 4 out of 6 screener items (denoted as 'Part A'), said participant will meet inclusion for the study.
The remaining 12 ASRS items ('Part B') will be administered for use in the event that the screener criteria are met, and thus a need for further psychometric gradation arises.
|
Measured at days 20 and 30. Day 20 serves as a quasi-baseline--following washout--for changes at Day 30 following exposure to video two.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Video Review Survey (VRS)
Time Frame: Administered on day 10 and day 30. These are the points in which participants will have completed exposure to videos one and two, respectively.
|
The VRS is a short questionnaire that participants will answer twice, each time following completion of a two-week video access block.
The VRS requests participants to provide their opinions on the video-and the strategies contained within-that they had access to for the previous month.
Through specific opinions, the investigators are better able to adapt future psychoeducational resources to the needs of people with ADHD.
|
Administered on day 10 and day 30. These are the points in which participants will have completed exposure to videos one and two, respectively.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 7850
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychoeducation
-
Agri Ibrahim Cecen UniversityCompletedMindfulness | Awareness | Psychoeducation | Defense MechanismsTurkey
-
Akdeniz UniversityNot yet recruitingWell-being | Mothers | Special Needs Children | PsychoeducationTurkey
-
Government College University FaisalabadActive, not recruiting
-
Aydin Adnan Menderes UniversityRecruiting
-
York UniversityNorth York General HospitalCompletedMotivational Interviewing | PsychoeducationCanada
-
Swansea UniversityCompletedA Bite of ACT' (BOA) Acceptance and Commitment Therapy Online Psychoeducation Course | A Wait-list ControlUnited Kingdom
-
University of Texas at AustinWithdrawnPsychoeducation on Trauma Reactions | Psychoeducation on Safety Behaviors and How to Fade Them | Monitoring-only Control
-
ŞİRİN HARKİNEnrolling by invitationSchizophrenia | Well-being | Caregiver | Psychoeducation | Communication SkillsTurkey
-
Akdeniz UniversityCompletedChronic Mental Disorder | PsychoeducationTurkey
-
Lisa WoodUnknownPsychoeducation | Cognitive Behaviour Therapy for Internalised StigmaUnited Kingdom
Clinical Trials on ADHD Psycheducation
-
The University of Hong KongRecruiting
-
Göteborg UniversityCompleted
-
Children's Hospital Medical Center, CincinnatiTerminated
-
Lumos Labs, Inc.Recruiting
-
Children's Hospital Medical Center, CincinnatiNational Institute of Mental Health (NIMH); Nationwide Children's HospitalCompleted
-
Children's Hospital Medical Center, CincinnatiCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Indiana UniversityNational Library of Medicine (NLM)CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven; Research Foundation FlandersActive, not recruiting
-
King's College LondonSouth London and Maudsley NHS Foundation TrustNot yet recruiting
-
Karolinska InstitutetRegion StockholmCompletedSleep Wake Disorders | Sleep Initiation and Maintenance Disorders | Attention Deficit DisorderSweden